weeks before initiating for non-live vaccines. Vaccination with live virus vaccines is not recommended during treatment and until B-cell repletion. Do not administer live or live-attenuated vaccines to infants of mothers exposed to ublituximab during pregnancy, before confirming recovery of B-cell counts as measured by CD19+ B cells. >10% (Boostrix) Pain (21.5%) Fatigue (12.5%) Headache (11.5%) Redness (10.8%) Swelling (7.5%) >10% (Adacel) Any injection site pain (65.7-77.8%) Malaise (30.8-33.3%) Headache (33.9-43.7%) Body ache or muscle weakness (21.9-30.4%) Tiredness (24.3-30.2%) Any injection site erythema (20.8-24.7%) Any injection site swelling (20.9-21%) Moderate injection site pain (15.1-18%) Chills (8.1-15.1%) Nausea (9.2-13.3%) Sore and swollen joints (9.1-11.3%) Diarrhea (10.3%) 1-10% (Boostrix) Gastrointestinal symptoms (7.6%) Swelling (7.5%) Fever (≥99.5°F [37.5°C]) 1-10% (Adacel) Body aches/muscle weakness (1.2-8.5%) Injection site erythema (2.7-8.4%) Lymph node swelling (6.5-6.6%) Injection site swelling (2.8-6.4%) Fever (1.4-5%) Vomiting (3-4.6%) Chills, moderate (1.3-3.2%) Nausea (1-3.2%) Rash (2-2.7%) Joint pain, moderate (2.5%) Severe injection site reactions (1.1-1.5%) Lymphadenopathy (1%) Contraindications Hypersensitivity Encephalopathy with 7 days of previously administered pertussis antigen History of Arthus reaction to prior tetanus vaccination (unless 10 yr have elapsed) Cautions Epinephrine and other emergency equipment should be available to respond to hypersensitivity reactions Not indicated for primary vaccination series; for children aged 6 months-7 yr, see DTaP Caution if Guillain-Barré syndrome and brachial neuritis has occurred with previously administered tetanus toxoid Caution with neurologic disorders (eg, epilepsy, CVA, encephalopathic condition) Defer vaccine if moderate or severe illness present Syncope has been associated with administration of injectable vaccine Attenuated immune response may occur with immunosuppressed conditions (eg, high-dose corticosteroids, use of antineoplastic agents, immunosuppressive illness) Prefilled syringes contain natural latex rubber Pregnancy There are no adequate and well-controlled studies of administration in pregnant women Available data suggest the rates of major birth defects and miscarriage in women who receive Tdap within 30 days prior to pregnancy or during pregnancy are consistent with estimated background rates Animal studies Adacel: Two developmental toxicity studies were performed in female rabbits given 0.5 mL (a single human dose) of Adacel twice prior and during gestation Boostrix: Developmental toxicity studies were performed in female rats and New Zealand White rabbits did not observe fetal abnormalities following vaccine administration before mating and during gestation Pregnancy registries Clinicians are encouraged to call and register women in the following pregnancy exposure registries Adacel: 1-800-822- 2463 (1-800-VACCINE) Boostrix: 1-888-452-9622 Lactation Unknown if distributed in human breast milk Consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for the drug, and any potential adverse effects on the breastfed infant from the drug or from the underlying maternal conditionPregnancy Categories A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk. B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available. Mechanism of Action Active immunization resulting in development of neutralizing antibodies to tetanus, diphtheria, and pertussis toxins These products convey active immunity via stimulation of production of endogenously produced antibodies Pharmacokinetics The onset of protection from disease is relatively slow, but duration is long lasting (years) Duration: Variable, possibly >10 yr; Tdap maternal pertussis antibodies appear to wane greatly between subsequent pregnancies IM Preparation Shake vigorously to obtain a homogeneous, turbid, white suspension before administration; do not use if resuspension does not occur with vigorous shaking Visually inspected for particulate matter and discoloration prior to administration, whenever solution and container permit Adacel or Boostrix vial: Withdraw 0.5 mL dose from vial using a sterile needle and syringe IM Administration IM administration only Do not administer IV, intradermally, or SC Storage All formulations: Refrigerate between 2-8°C (36-46°F); do not freeze BRAND FORM. UNIT PRICE PILL IMAGE Adacel (Tdap Adolescent/Adult)(PF) intramuscular- 2 Lf-(2.5-5-3-5 mcg)-5Lf/0.5 mL vialCopyright © 2010 First DataBank, Inc.Print Patient Educationdiphtheria,pertussis(acel)tetanus vaccine (PF) intramuscular DIPHTHERIA/TETANUS/ACELLULAR PERTUSSIS VACCINE - INJECTION (dip-THEER-ee-uh/TET-un-us/per-TUSS-iss) COMMON BRAND NAME(S): Adacel, Boostrix USES: This vaccine is used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past. It may also be given during the third trimester of pregnancy to help prevent pertussis in the newborn baby. Vaccination is the best way to protect against these life-threatening diseases. Vaccines work by causing the body to produce its own protection (antibodies). Booster doses are needed to keep up immunity because antibody levels may become too low over time to provide the needed protection. HOW TO USE: Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional.This medication is given by injection into a muscle by a health care professional. It is usually given in the upper arm.This vaccine may be given at the same time as other vaccines (such as hepatitis B) using a separate needle and injection site. SIDE EFFECTS: Pain, swelling, or redness at the injection site may occur. Headache, tiredness, body aches, nausea, diarrhea, fever, chills, vomiting, or sore/swollen joints may also occur. Acetaminophen or ibuprofen (non-aspirin) may be used to reduce soreness. If any of these effects last or get worse, tell your health care professional promptly.Rarely, some people have symptoms such as fainting, dizziness, vision changes, or ringing in the ears just after getting a vaccine injection. Tell your health care professional right away if you have any of these symptoms. Sitting or lying down may help, since these symptoms usually don't last long.Remember that this medication has been prescribed because your health care professional has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.Tell your health care professional right away if you have any serious side effects, including: high fever (higher than 104 degrees F/40 degrees C), seizures, numbness/tingling, muscle weakness, difficulty breathing.A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.This is not a complete list of possible side effects. If you notice other effects not listed above, contact your health care professional.Contact the health care professional for medical advice about side effects. The following numbers do not provide medical advice, but in the US you may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967. In Canada, you may call the Vaccine Safety Section at Public Health Agency of Canada at 1-866-844-0018. PRECAUTIONS: Before receiving this vaccination, tell your health care professional if you are allergic to it; or to any other vaccines; or if you have any other allergies. This product may contain inactive ingredients (such as latex), which can cause allergic reactions or other problems. Talk to your health care professional for more details.Before receiving this vaccine, tell your health care professional your medical history, especially of: nervous system disorders (such as seizures, encephalopathy, Guillain-Barre syndrome), current illness/infection, immune system disorders (such as due to HIV infection, certain cancers such as leukemia/lymphoma, cancer or radiation treatment), vaccination history including previous reactions to any vaccines.During pregnancy, this vaccine is usually recommended. Discuss the risks and benefits with your health care professional.It is unknown if this vaccine passes into breast milk. Consult your health care professional before breast-feeding. DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your health care professional. Do not start, stop, or change the dosage of any medicines without your doctor's approval.Some products that may interact with this vaccine include: drugs that weaken the immune system (including cyclosporine, tacrolimus, cancer chemotherapy, corticosteroids such as prednisone), other vaccines (such as diphtheria/tetanus toxoids). OVERDOSE: Not applicable. NOTES: There are various combinations of vaccines available. Based on your age, vaccination history, and previous reaction to vaccines, your health care professional will determine the most appropriate one for you. Discuss the risks and benefits of vaccination with your health care professional.History of infection with tetanus or diphtheria does not always protect against future infections with these bacteria. You should still receive this vaccine if your health care professional orders it for you. MISSED DOSE: It is important to receive each vaccination as scheduled. Be sure to make a note of when the vaccination was last given for your medical record. STORAGE: Store in the refrigerator. Do not freeze. Keep all medications away from children and pets.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company. Information last revised October 2022. Copyright(c) 2023 First Databank, Inc. IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs. FormularyPatient DiscountsAdding plans allows you to compare formulary status to other drugs in the same class.To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.Create Your List of PlansAdding plans allows you to:View the formulary and any restrictions for each plan.Manage and view all your plans together – even plans in different states.Compare formulary status to other drugs in the same class.Access your plan list on any device – mobile or desktop. The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information. View explanations for tiers and restrictions Tier Description 1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs. 2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs. 3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs. 4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products. 5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products. 6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products. NC NOT COVERED – Drugs that are not covered by the plan. Code Definition PA Prior Authorization Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription. QL Quantity Limits Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered. ST Step Therapy Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription. OR Other Restrictions Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription. Plans Select State: Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Done Non-Medicare Plans Medicare Plans Done CLOSE Additional Offers CLOSE Email to